On March 7 a leading healthcare blockchain data company BurstIQ partnered with a provider of personalized testing products and cytometry services FlowMetric Life Sciences. As the first stage of cooperation, BurstIQ will handle data management of FlowMetric blockchain-based platform. With the adoption of blockchain platform clients will be able to acquire personalized testing devices that include enhanced data security, full control over their own testing results, i.e. the usage and sharing of the data.
Blockchain is a game-changer. The BurstIQ platform will allow us to offer a level of service to both our enterprise and individual customers that is truly best in class. In addition, it opens new distribution and partnership channels that allow us to accelerate our growth.
Along with a default set of products, there is a space for premium line like chromosomal age tests, toxicity, oxidative stress, inflammation, etc. This full suite will become available on BurstIQ healthcare marketplace and be based on BurstIQ monetization engine - BIQ token.
Upon expansion, the blockchain platform will implement its advanced machine intelligence layer and offer such platform to FlowMetric's customers. Eventually, this flow will create a secure and auditable chain of custody of clients' samples and data.
We're thrilled to partner with FlowMetric. Our partnership with them will create the first cryptocurrency-enabled personalized medicine marketplace for consumers. In addition, we will be able to successfully demonstrate how blockchain solves the institutional data challenges impacting the biopharma sector. It opens the door for an entirely new way of doing business.